Cargando…

Effects of attentional bias modification on chronic low back pain in older outpatients: A randomized crossover trial (pilot study)

OBJECTIVES: In the present study, the effect of attentional bias modification (ABM) on older outpatients, with chronic low back pain, was examined. DESIGN: This was a single-center, randomized, single-blinded, crossover trial and patients were randomly divided in a 1:1 allocation ratio into two grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Takashi, Nishi, Keita, Nakashima, Akira, Moriuchi, Takefumi, Iso, Naoki, Koseki, Hironobu, Tabira, Takayuki, Higashi, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545343/
https://www.ncbi.nlm.nih.gov/pubmed/34766584
http://dx.doi.org/10.1097/MD.0000000000027738
Descripción
Sumario:OBJECTIVES: In the present study, the effect of attentional bias modification (ABM) on older outpatients, with chronic low back pain, was examined. DESIGN: This was a single-center, randomized, single-blinded, crossover trial and patients were randomly divided in a 1:1 allocation ratio into two groups: an ABM Leading group and an ABM Trailing group. PARTICIPANTS: Forty-three outpatients with chronic low back pain participated. INTERVENTIONS: Patients were evaluated four times and the treatments were ABM + Normal intervention or Normal intervention only. OUTCOMES: Outcome measures included pain intensity on the Numerical Rating Scale, the Pain Catastrophizing Scale, Fear-Avoidance Beliefs Questionnaire, Hospital Anxiety and Depression Scale, Somatic Symptom Scale-8, and EuroQol 5 Dimension-3 levels questionnaire. In addition, we performed the 30-second Chair-Stand test and the Timed Up & Go test for physical function evaluations. RESULTS: There was no change in pain intensity due to ABM. However, the total Pain Catastrophizing Scale score was significantly decreased, and the EuroQol 5 Dimension-3 levels questionnaire and 30-second chair-stand test were significantly improved (P <.05). TRIAL REGISTRATION: The Health Science Ethics Committee, Graduate School of Biomedical Sciences, Nagasaki University (permit number: 17060861), and the clinical trial was registered with UMIN (UMIN000029424).